InvestorsHub Logo
Followers 5
Posts 50
Boards Moderated 0
Alias Born 06/13/2020

Re: Grip it and Sip It post# 91359

Monday, 07/06/2020 9:09:31 PM

Monday, July 06, 2020 9:09:31 PM

Post# of 233066
Please enlighten me as to why Pfizer would buy Leronlimab? They already own a CCR5 blocker and it was FDA approved back in 2007. Maraviroc is the name of the drug. Why would they compete with themselves by purchasing CYDY. Just of note, Pfizer never made any money on Maraviroc as an HIV medicine. Pfizer's drug is far from perfect having liver issues and strong side effect profile. However, I do not see them purchasing a second CCR5 inbibitor at least not one so similar to the one they already own.

Here is a simple description of all the CCR5 inhibitors. Too my knowledge only one, Maraviroc has FDA approval.

https://en.wikipedia.org/wiki/CCR5_receptor_antagonist#Aplaviroc_2
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News